Search results for "Authorization"

showing 10 items of 32 documents

Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005)

2017

Efsa Panel On Genetically Modified Organisms (gmo) Requestor: European Commission (DG SANTE)Question number: EFSA-Q-2016-00714Correspondence; Following the submission of application EFSA-GMO-RX-005 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide-tolerant genetically modified maize GA21. The data received in the context of this renewal application contained post-market environmental monitoring reports, a systematic search and eval…

0106 biological sciencesmaïsVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Context (language use)TP1-1185Plant Science010501 environmental sciencesOriginal Applicationmaize01 natural sciencesMicrobiologyGenetically modified soybeanzea maysGA21articles 11 and 23media_common.cataloged_instanceTX341-641European union0105 earth and related environmental sciencesmedia_common2. Zero hungerrenewalNutrition. Foods and food supplybusiness.industryindian cornChemical technologyfungiAuthorizationRegulation (EC) No 1829/200310079 Institute of Veterinary Pharmacology and ToxicologyFood safetyGenetically modified organismBiotechnologyScientific Opinionmaize;GA21 renewal;Regulation (EC) No 1829/2003;articles 11 and 23Regulation (EC) No1829/2003570 Life sciences; biologyAnimal Science and ZoologyParasitologyRisk assessmentbusinessRegulation (EC) No 1829/2003010606 plant biology & botanyFood Science
researchProduct

Myotonic dystrophy type 1 drug development: A pipeline toward the market

2021

Highlights • Myotonic dystrophy, a neuromuscular disease, affects at least around half a million people worldwide. • Close to two dozen preclinical and clinical drug development programs active. • Drugs encompass new chemical entities, repurposing, oligonucleotide, and gene therapy. • Tideglusib, mexiletine, and metformin are close to reaching marketing authorization.

0301 basic medicineDrugmedia_common.quotation_subjectMyotonic dystrophyDiseaseBioinformaticsMarketing authorizationMyotonic dystrophy03 medical and health sciences0302 clinical medicineGene therapyDrug DevelopmentDrug DiscoveryMedicineAnimalsHumansAntisense oligonucleotideRepurposingmedia_commonPharmacologybusiness.industryRepurposing drugmedicine.diseaseClinical trialClinical trialDrug repositioning030104 developmental biologyDrug development030220 oncology & carcinogenesisbusinessPost-Screen (Grey)Drug Discovery Today
researchProduct

Scientific Opinion on application EFSA‐GMO‐BE‐2013‐118 for authorisation of genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 591…

2017

Abstract In this opinion, the GMO Panel assessed the five‐event stack maize MON 87427 × MON 89034 ×1507 × MON 88017 × 59122 and its 25 subcombinations, independently of their origin. The GMO Panel has previously assessed the five single events combined to produce this five‐event stack maize and 11 subcombinations of these events and did not identify safety concerns. No new data on the single events or their previously assessed subcombinations, leading to modification of the original conclusions were identified. The combination of the single events and of the newly expressed proteins in the five‐event stack maize did not give rise to issues – based on the molecular, agronomic/phenotypic or c…

040301 veterinary sciencesherbicide toleranceVeterinary (miscellaneous)Context (language use)Plant ScienceGenetically modified crops010501 environmental sciencesBiologymaize01 natural sciencesMicrobiology0403 veterinary scienceEnvironmental safety0105 earth and related environmental sciencesGenetically modified maizebusiness.industryGMOAuthorizationGMO;maize;MON 87427 x MON 89034 x 1507 x MON 88017 x 59122;herbicide tolerance;insect resistance04 agricultural and veterinary sciencesFood safetyZea maysBiotechnologyGenetically modified organismMON87427xMON89034x1507xMON88017x59122Scientific OpinionSettore AGR/11 - Entomologia Generale E ApplicataMON 87427 × MON 89034 × 1507 × MON 88017 × 59122Animal Science and ZoologyParasitologyinsect resistancebusinessFood Science
researchProduct

Trends in individual reimbursement of orphan drugs in Latvia in 2008–2011

2014

Orphan drugs (ODs) are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases affecting less than 5 in 10 000 people in the European Union (EU). These drugs are called “orphans” because the pharmaceutical industry has little interest, under normal market conditions, in developing and marketing products intended for only a small number of patients suffering from very rare conditions. Because of the small market, ODs are often very expensive. Whereas decisions surrounding orphan designation and marketing authorization of ODs are taken at the EU level, decisions governing pricing and reimbursement of ODs are a member state responsibility…

Actuarial sciencebusiness.industryDrug reimbursementMarketing authorizationlcsh:Social Scienceslcsh:HOrphan drugMember stateMedicinemedia_common.cataloged_instancePer patient per yearEuropean unionbusinessReimbursementPharmaceutical industrymedia_commonSHS Web of Conferences
researchProduct

Analyzing the security of Windows 7 and Linux for cloud computing

2013

We review and analyze the major security features and concerns in deploying modern commodity operating systems such as Windows 7 and Linux 2.6.38 in a cloud computing environment. We identify the security weaknesses and open challenges of these two operating systems when deployed in the cloud environment. In particular, we examine and compare various operating system security features which are critical in providing a secure cloud. These security features include authentication, authorization and access control, physical memory protection, privacy and encryption of stored data, network access and firewalling capabilities, and virtual memory.

AuthenticationCloud computing securityGeneral Computer ScienceComputer sciencebusiness.industryAuthorizationData securityAccess controlCloud computingInformation securityComputer security modelAsset (computer security)EncryptionInternet securityComputer securitycomputer.software_genreSecurity and safety features new to Windows VistaSecurity information and event managementSecurity serviceNetwork Access ControlSecurity through obscuritybusinessLawcomputerComputers & Security
researchProduct

Mutual entity authentication for LTE

2011

In this paper we outline the Authentication and Key Agreement protocol (EPS-AKA) found in Long-Term Evolution (LTE) systems. This architecture is the 3GPP version of a 4G access security architecture. The LTE security architecture is a mature evolved architecture, with both strengths and weaknesses. In this paper we propose an amendment to the EPS-AKA protocol to make it a full mutual (online) entity authentication protocol. We also analyze the proposal, highlighting both the improvements and the drawbacks of the new AKA protocol.

Challenge-Handshake Authentication ProtocolKey-agreement protocolAuthenticationbusiness.industryComputer scienceAuthorizationMutual authenticationEnterprise information security architectureCryptographic protocolComputer securitycomputer.software_genreDistributed System Security ArchitectureGSMAuthentication protocolLightweight Extensible Authentication ProtocolbusinesscomputerAKAComputer network2011 7th International Wireless Communications and Mobile Computing Conference
researchProduct

The Polyphonic Theology of the Church Fathers

2014

Prof. Dr. Dres. H. c. Christoph Marschies (Humboldt University Berlin, Germany) in collaboration with Prof. Dr. Michael Welker (Heidelberg University, Germany) initiated an international project to which about 25 international scholars of high profile were invited to participate. The purpose of the project is to gain a new and nuanced perspective on the theology of 19 church fathers: Justin the Martyr, Irenaeus of Lyon, Tertullian, Origen, Cyprian, Eusebius, Athanasius of Alexandria, Basil the Great, Gregory of Nazianzus, Gregory of Nyssa, John Chrysostom, Augustine, Cyril of Alexandria, Leo the Great, Theodoret of Cyrus, Boethius, Isidore, Maximus the Confessor and John Damascene. Research…

Church FathersPerspective (graphical)AuthorizationJohn ChrysostomPolyphonySociologyTheologyCoherence (linguistics)Order (virtue)MartyrReview of Ecumenical Studies Sibiu
researchProduct

Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use

2015

During the past decade, a large number of cell-based medicinal products have been tested in clinical trials for the treatment of various diseases and tissue defects. However, licensed products and those approaching marketing authorization are still few. One major area of challenge is the manufacturing and quality development of these complex products, for which significant manipulation of cells might be required. While the paradigms of quality, safety and efficacy must apply also to these innovative products, their demonstration may be demanding. Demonstration of comparability between production processes and batches may be difficult for cell-based medicinal products. Thus, the development …

Clinical Trials as TopicEmbryologyComputer scienceManufacturing processStem Cellsmedia_common.quotation_subjectControl (management)CommerceBiomedical EngineeringMarketing authorizationSocial Control FormalQuality developmentProduct (business)Risk analysis (engineering)HumansQuality (business)European UnionStem Cell Transplantationmedia_commonCell basedRegenerative Medicine
researchProduct

Monitoring resource consumption and anthropogenic substances in the EU and Latvia

2011

PurposeThe aim of this paper is to assess how the indicator sets presently used to monitor sustainable development in the European Union (EU) and Latvia reflect resource consumption and the production and use of anthropogenic substances.Design/methodology/approachThe study was conducted by analyzing different sources as well as statistical information on development character in Latvia and human impact at first in respect to use of chemicals.FindingsMany of the analyzed sustainable development indicators related to resource consumption interpret a reduction in consumption as a negative phenomena and thus contradictory to sustainability. The only relevant EU and Latvian indicator related to …

Consumption (economics)Sustainable developmentbusiness.industryEnvironmental resource managementPublic Health Environmental and Occupational HealthAuthorizationLatvianManagement Monitoring Policy and Lawlanguage.human_languageSustainabilitylanguageProduction (economics)media_common.cataloged_instanceBusinessResource consumptionEuropean unionEnvironmental planningmedia_commonManagement of Environmental Quality: An International Journal
researchProduct

Autorizzazioni amministrative e liberalizzazione dei mercati tra diritto europeo e diritto interno

2018

Il libro ripercorre le trasformazioni della disciplina nazionale delle autorizzazioni amministrative per l'influenza del diritto dell'Unione europea che ha profondamente modificato la base giuridica del potere autorizzatorio. Dopo un'ampia premessa dedicata all'affermazione delle politiche di liberalizzazione in Europa, un'ampia parte del lavoro è rivolta ad esaminare i nuovi principi in materia di procedimenti autorizzatori che si possono ricavare dalla giurisprudenza della Corte di giustizia e dalla normativa europea. Inoltre, sono analizzati i cambiamenti che hanno riguardato i diversi settori nazionali in cui trovano applicazione le autorizzazioni amministrative, per dimostrare la progr…

DIRITTO AMMINISTRATIVO - AUTORIZZAZIONI - LIBERALIZZAZIONI - DIRITTO EUROPEOSettore IUS/10 - Diritto AmministrativoADMINISTRATIVE LAW - AUTHORIZATIONS - LIBERALIZATION - EUROPEAN UNION LAW
researchProduct